Koyfin Home > Directory > Health Care > Acorda Therapeutics > Total Debt / Equity

Acorda Therapeutics Total Debt / Equity Chart (ACOR)

Acorda Therapeutics annual/quarterly Total Debt / Equity from 2010 to 2020. Debt to equity is a measure of leverage in a company and expressed as a ratio of the total debt relative to book value of equity.
  • Acorda Therapeutics Total Debt / Equity for the quarter ending June 06, 2020 was $87m a -56.80% decrease of -49m year over year
  • Acorda Therapeutics Total Debt / Equity for the last 12 months ending June 06, 2020 was $87m a -56.80% decrease of -49m year over year
  • Acorda Therapeutics Annual Total Debt / Equity for 2019 was $80m a 30.06% increase of 24m from 2018
  • Acorda Therapeutics Annual Total Debt / Equity for 2018 was $56m a -14.74% decrease of -8m from 2017
  • Acorda Therapeutics Annual Total Debt / Equity for 2017 was $64m a 22.66% increase of 15m from 2016
Other Ratios Metrics:
  • Acorda Therapeutics Total Debt / Capital for the quarter ending December 12, 2018 was $36m a -5.79% decrease of -2m year over year
  • Acorda Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $204m a 10.59% increase of 22m year over year
View Chart On Koyfin

Quarterly ACOR Total Debt / Equity Data

06/2020$87m
03/2020$82m
12/2019$80m
09/2019$136m
06/2019$70m
03/2019$67m
12/2018$56m
09/2018$57m
06/2018$56m
03/2018$61m

Annual ACOR Total Debt / Equity Data

2019$80m
2018$56m
2017$64m
2016$50m
2015$49m
2014$54m
2013$1m
2012$1m
2011$3m
2010$5m